PRF Technologies Announces PRF-110 Demonstrated Sustained 72-Hour Analgesic Activity Comparable to Approved, Commercially Available Benchmark in Head-to-Head Preclinical Study

Go back to PRF Technologies Announces PRF-110 Demonstrated Sustained 72-Hour Analgesic Activity Comparable to Approved, Commercially Available Benchmark in Head-to-Head Preclinical Study
(NASDAQ: PRFX) Delayed: 1.60 --0 (-0%)
Previous Close $1.60    52 Week High
Open $1.60    52 Week Low
Day High $1.60    P/E N/A 
Day Low $1.60    EPS
Volume 6,608